Standard BioTools Inc.
LAB
$1.01
-$0.01-0.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 189.85% | 19.61% | -62.61% | -65.23% | 3.25% |
| Total Depreciation and Amortization | -13.08% | -24.79% | 133.16% | -2.99% | -27.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -812.69% | 1,085.62% | 1,617.69% | 808.66% | 2,232.96% |
| Change in Net Operating Assets | -151.63% | -78.68% | 83.13% | 29.36% | 26.43% |
| Cash from Operations | 18.52% | 48.18% | 39.21% | 26.87% | -14.37% |
| Capital Expenditure | 64.28% | -29.37% | -259.96% | -613.04% | -310.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.49% | -100.49% | -100.49% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -821.91% | -12.23% | 2,693.85% | 319.20% | 21.53% |
| Cash from Investing | 241.36% | -92.45% | -81.14% | -87.89% | -79.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -482.50% | -435.28% | -435.28% |
| Issuance of Common Stock | 90.89% | 58.50% | 48.48% | 57.24% | -34.04% |
| Repurchase of Common Stock | -245.34% | 95.67% | 96.44% | 96.90% | 98.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 100.00% |
| Cash from Financing | 100.69% | 100.56% | -11.14% | -8.35% | -245.77% |
| Foreign Exchange rate Adjustments | 288.68% | 220.98% | 439.20% | 658.06% | -3,080.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 184.82% | -139.14% | -160.79% | -185.86% | -177.56% |